BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 236 filers reported holding BLUEBIRD BIO INC in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $147,945 | +76954.7% | 48,666 | -16.5% | 0.01% | -18.2% |
| Q2 2023 | $192 | -39.8% | 58,274 | -41.9% | 0.01% | -45.0% |
| Q1 2023 | $319 | -55.3% | 100,324 | -2.7% | 0.02% | -54.5% |
| Q4 2022 | $714 | -99.9% | 103,139 | +11.1% | 0.04% | +12.8% |
| Q3 2022 | $588,000 | +49.2% | 92,857 | -2.5% | 0.04% | +62.5% |
| Q2 2022 | $394,000 | -10.0% | 95,211 | +5.3% | 0.02% | +4.3% |
| Q1 2022 | $438,000 | -37.0% | 90,376 | +30.0% | 0.02% | -32.4% |
| Q4 2021 | $695,000 | -0.1% | 69,541 | +90.9% | 0.03% | -8.1% |
| Q3 2021 | $696,000 | -9.1% | 36,421 | +52.1% | 0.04% | -9.8% |
| Q2 2021 | $766,000 | +277.3% | 23,951 | +256.2% | 0.04% | +241.7% |
| Q1 2021 | $203,000 | – | 6,724 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |